The genomics personalized health market will hit $25.1 million by the end of 2025, according to a Transparency Market Research report.
In 2016, the market sat at $7.2 million. Between 2017 and 2025, Transparency Market Research estimates the market will grow at a compound annual growth rate of 14.9 percent.
Qiagen, F. Hoffman-La Roche, and Illumina lead the expanding market.
Transparency Market Research expects the next-generation sequencing segment to dominate the global personalized health market. It also noted increasing investment toward research and development of biomarkers have already helped propel the industry forward.
More articles on health IT:
Cerner names new leadership for Middle East region